GWM
PFE icon

GSB Wealth Management’s Pfizer PFE Stock Holding History

GSB Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$703K Sell
29,199
-958
-3% -$25.1K 0.14% 128
2026
Q1 		$847K Sell
30,157
-5,314
-15% -$141K 0.19% 110
2025
Q4 		$883K Buy
35,471
+7,252
+26% +$183K 0.2% 108
2025
Q3 		$719K Sell
28,219
-16,476
-37% -$407K 0.16% 117
2025
Q2 		$1.08M Sell
44,695
-7,085
-14% -$165K 0.27% 99
2025
Q1 		$1.31M Sell
51,780
-8,613
-14% -$225K 0.34% 95
2024
Q4 		$1.6M Sell
60,393
-45,187
-43% -$1.23M 0.41% 76
2024
Q3 		$3.06M Buy
105,580
+1,618
+2% +$47.2K 0.78% 37
2024
Q2 		$2.91M Buy
103,962
+4,905
+5% +$135K 0.79% 36
2024
Q1 		$2.75M Buy
99,057
+17,127
+21% +$475K 0.77% 39
2023
Q4 		$2.36M Sell
81,930
-11,068
-12% -$335K 0.73% 43
2023
Q3 		$3.08M Buy
92,998
+4,978
+6% +$176K 1.03% 22
2023
Q2 		$3.23M Buy
88,020
+35,867
+69% +$1.4M 1.05% 19
2023
Q1 		$2.13M Sell
52,153
-7,871
-13% -$340K 0.7% 46
2022
Q4 		$3.08M Sell
60,024
-3,148
-5% -$151K 1.1% 25
2022
Q3 		$2.76M Sell
63,172
-487
-0.8% -$23.7K 1% 24
2022
Q2 		$3.34M Buy
63,659
+219
+0.3% +$11.2K 1.14% 22
2022
Q1 		$3.28M Sell
63,440
-1,824
-3% -$94.6K 0.96% 28
2021
Q4 		$3.85M Buy
65,264
+40,597
+165% +$2.01M 1.11% 21
2021
Q3 		$1.06M Sell
24,667
-40,688
-62% -$1.8M 0.55% 57
2021
Q2 		$2.56M Buy
65,355
+6,783
+12% +$264K 0.8% 33
2021
Q1 		$2.12M Buy
+58,572
New +$2.08M 0.71% 44

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GSB Wealth Management's PFE Position: Q2 2026 in Review

GSB Wealth Management reduced its Pfizer (PFE) stake by 3.2% in Q2 2026, selling an estimated $25.1K and leaving 29,199 shares worth $703K. The position accounts for 0.14% of the portfolio, ranked #128.

GSB Wealth Management first reported a position in PFE in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.85M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • GSB Wealth Management held 29,199 shares of Pfizer worth $703K as of Q2 2026.
  • GSB Wealth Management sold 958 Pfizer shares in Q2 2026, an estimated $25.1K.
  • Pfizer made up 0.14% of GSB Wealth Management's portfolio in Q2 2026, its #128 holding.
  • GSB Wealth Management first reported a position in Pfizer in Q1 2021 and has held it in 22 quarters since.
  • GSB Wealth Management's Pfizer position peaked at $3.85M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GSB Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.